Genetic variations in IL6 and IL12B decreasing the risk for psoriasis

Immunology Letters

Volumn 156, Issue 1-2, 2013, Pages 127-131

  Boca, Andreea Nicoleta ^a   Talamonti, Marina ^b   Galluzzo, Marco ^b   Botti, Elisabetta ^b   Vesa, Ştefan Cristian ^a   Chimenti, Sergio ^b   Buzoianu, Anca Dana ^a   Costanzo, Antonio ^c  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

HLA Cw6; IL12B SNP; IL23R SNP; IL6 SNP; Psoriasis protective loci

Indexed keywords

CYTOSINE; GUANINE; HLA C ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 6;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HLA CW6 GENE; HUMAN; IL12B GENE; IL23R GENE; IL6 GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; RISK ASSESSMENT; RISK REDUCTION; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM;

HLA-CW6; IL12B SNP; IL23R SNP; IL6 SNP; PSORIASIS PROTECTIVE LOCI;

ADULT; FEMALE; GENE FREQUENCY; GENOTYPE; HLA-C ANTIGENS; HUMANS; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; RECEPTORS, INTERLEUKIN; RISK FACTORS;

EID: 84887006980     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.09.028     Document Type: Article

References (27)

1. Jacobson C.C., Kumar S., Kimball A.B. Latitude and psoriasis prevalence. J Am Acad Dermatol 2011, 65:870-873.
2. Saraceno R., Mannheimer R., Chimenti S. Regional distribution of psoriasis in Italy. J Eur Acad Dermatol Venereol 2008, 22:324-329.
3. Cargill M., Schrodi S.J., Chang M., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007, 80:273-290.
4. Kurd S.K., Troxel A.B., Crits-Christoph P., Gelfand J.M. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010, 146:891-895.
5. Catanoso M., Pipitone N., Salvarani C. Epidemiology of psoriatic arthritis. Reumatismo 2012, 64:66-70.
6. Armstrong A.W., Schupp C., Bebo B. Psoriasis comorbidities results from the National Psoriasis Foundation Surveys 2003-2011. Dermatology 2012, 225:121-126.
7. Griffiths C.E., Barker J.N. Pathogenesis and clinical features of psoriasis. Lancet 2007, 370:263-271.
8. Lowes M.A., Bowcock A.M., Krueger J.G. Pathogenesis and therapy of psoriasis. Nature 2007, 445:866-873.
9. Elder J.T., Bruce A.T., Gudjonsson J.E., Johnston A., Stuart P.E., Tejasvi T., et al. Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol 2010, 130:1213-1226.
10. Duffin K.C., Krueger G.G. Genetic variations in cytokines and cytokine receptors associated with psoriasis found by genome-wide association. J Invest Dermatol 2009, 129:827-833.
11. Di Cesare A., Di Meglio P., Nestle F.O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 2009, 129:1339-1350.
12. Zhu K.J., Zhu C.Y., Shi G., Fan Y.M. Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis. Rheumatol Int 2013, 33(7):1785-1790.
13. Nair R.P., Ruether A., Stuart P.E., Jenisch S., Tejasvi T., Hiremagalore R., et al. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J Invest Dermatol 2008, 128:1653-1661.
14. Suttle M.M., Nilsson G., Snellman E., Harvima I.T. Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor. Clin Exp Immunol 2012, 169:311-319.
15. Goodman W.A., Levine A.D., Massari J.V., Sugiyama H., McCormick T.S., Cooper K.D. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J Immunol 2009, 183:3170-3176.
16. Kishimoto T. IL-6: from its discovery to clinical applications. Int Immunol 2010, 22:347-352.
17. Lindroos J., Svensson L., Norsgaard H., Lovato P., Moller K., Hagedorn P.H., et al. IL-23-mediated epidermal hyperplasia is dependent on IL-6. J Invest Dermatol 2011, 131(5):1110-1118.
18. Settin A.A., Hassan H.A., El-Baz R.A., Hassan T.A. Association of cytokine gene polymorphisms with psoriasis in cases from the nile delta of egypt. Indian J Dermatol 2011, 56:272-277.
19. Popa O.M., Kriegova E., Popa L., Schneiderova P., Dutescu M.I., Bojinca M., et al. Association study in Romanians confirms IL23A gene haplotype block rs2066808/rs11171806 as conferring risk to psoriatic arthritis. Cytokine 2013, 63(1):67-73.
20. Eiris N., Santos-Juanes J., Coto-Segura P., Gómez J., Alvarez V., Morales B., et al. Resequencing of the IL12B gene in psoriasis patients with the rs6887695/rs3212227 risk genotypes. Cytokine 2012, 60(1):27-29.
21. Tsoi L.C., Spain S.L., Knight J., Ellinghaus E., Stuart P.E., Capon F., et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 2012, 44:1341-1348.
22. Di Meglio P., Di Cesare A., Laggner U., Chu C.C., Napolitano L., Villanova F., et al. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLoS ONE 2011, 6(2):e17160.
23. Kristiansen O.P., Nolsøe R.L., Larsen L., et al. Association of a functional 17beta-estradiol sensitive IL6-174G/C promoter polymorphism with early-onset type 1 diabetes in females. Hum Mol Genet 2003, 12:1101-1110.
24. Talamonti M., Botti E., Galluzzo M., Teoli M., Spallone G., Bavetta M., et al. Pharmacogenetics of Psoriasis: HLACw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to IL12/23 blocker ustekinumab. Br J Dermatol 2013, [Epub ahead of print].
25. Rodriguez S., Gaunt T.R., Day I.N.M. Hardy-Weinberg equilibrium testing of biological ascertainment for mendelian randomization studies. Am J Epidemiol 2009, 169:505-514.
26. Baran W., Szepietowski J.C., Mazur G., Baran E. IL-6 and IL-10 promoter gene polymorphisms in psoriasis vulgaris. Acta Derm Venereol 2008, 88:113-116.
27. Cénit M.C., Simeón C.P., Vonk M.C., et al. Influence of the IL6 gene in susceptibility to systemic sclerosis. J Rheumatol 2012, 39(12):2294-2302.